Oncology Times(@OncologyTimes) 's Twitter Profile Photo

Futibatinib is approved for adults with previously treated, unresectable, locally advanced, or metastatic intrahepatic harboring FGFR2 gene fusions. It received FDA approval through the accelerated approval pathway. ow.ly/8Js850OVOxA

Futibatinib is approved for adults with previously treated, unresectable, locally advanced, or metastatic intrahepatic #cholangiocarcinoma harboring FGFR2 gene fusions. It received FDA approval through the accelerated approval pathway. ow.ly/8Js850OVOxA
account_circle
Anthony J. Davis(@AnthonyjdavisL) 's Twitter Profile Photo

Today, we celebrate the life of my friend and colleague Dr. Benjamin Chen. Ben passed away two weeks ago after a battle with cholangiocarcinoma. The outpouring from around the world illustrates how great of a man Ben was. Excellent scientific mind, collaborative, and so giving.

Today, we celebrate the life of my friend and colleague Dr. Benjamin Chen. Ben passed away two weeks ago after a battle with cholangiocarcinoma. The outpouring from around the world illustrates how great of a man Ben was. Excellent scientific mind, collaborative, and so giving.
account_circle
Stephen Congly(@sconglymd) 's Twitter Profile Photo

Arndt Vogel concludes the PG course with discussion about cholangiocarcinoma. Increasing treatment options. Molecular testing recommended for treatment selection EASL Education

@ArndtVogel concludes the #EASLCongress PG course with discussion about cholangiocarcinoma. Increasing treatment options. Molecular testing recommended for treatment selection #LiverTwitter @EASLedu
account_circle
Rare Disease Advisor(@RareDisease_Adv) 's Twitter Profile Photo

The genomic profiles of patients with , who are 45 years of age and younger, are different than that of patients older than 45 years of age, found a new study published in the journal Cancer Biology and Therapy.

➡️ Read more: fal.cn/3zm2N

account_circle
Sebden Steel(@SebdenSteel) 's Twitter Profile Photo

Sebden sponsored and would like to congratulate Scott Oddy and his team for successfully completing the National Three Peaks Challenge (Ben Nevis/Scafell Pike/Snowden).
The team did a brilliant job and raised £1669 for AMMF, the UK’s only cholangiocarcinoma charity.

Sebden sponsored and would like to congratulate Scott Oddy and his team for successfully completing the National Three Peaks Challenge (Ben Nevis/Scafell Pike/Snowden).
The team did a brilliant job and raised £1669 for AMMF, the UK’s only cholangiocarcinoma charity.
#SebdenSteel
account_circle
Cholangiocarcinoma Foundation(@curecc) 's Twitter Profile Photo

The American Society of Clinical Oncology (ASCO) meeting took place in Chicago the first week of June. Enjoy five updates that our attendees found most beneficial.

cholangiocarcinoma.org/five-for-frida…

account_circle
EURO-CHOLANGIO-NET(@CholangioNet) 's Twitter Profile Photo

🔎Looking for a lab hosting your MarieSkłodowskaCurie fellowship?🧑‍🔬
👉Don't miss our new program 'COST for MSCA'!
✅Platform of available hosting mentors/labs in our network 🥼
✅Training for developing a successful application 📝
🗓️ 1st webinar: 26 June
🌐Info: bit.ly/CholangioMSCA

account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

🔥Options & Opportunities in : Novel Approaches for Targeting FGFR Alterations
🧐What Are the Options? Interested?
👉PeerVoice activity by Angela Lamarca Lorenza Rimassa & Arndt Vogel
👇 ime2.peervoice.com/505204742/5052…
ESMO - Eur. Oncology OncoAlert @Easledu Milca Malary Cholangiocarcinoma Foundation

🔥Options & Opportunities in #Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
🧐What Are the Options? Interested?
👉PeerVoice activity by @DrAngelaLamarca @LorenzaRimassa &  @ArndtVogel
👇 ime2.peervoice.com/505204742/5052…
@myESMO @OncoAlert @Easledu @ilca @curecc…
account_circle
Zhengqing Lei(@flyoop) 's Twitter Profile Photo

Exciting news! I am thrilled to share our real-world study about intrahepatic cholangiocarcinoma in Alimentary Pharmacology & Therapeutics. onlinelibrary.wiley.com/doi/10.1111/ap…
Our study shed light on the effect of different PD-1 inhibitor combination therapies for unresectable ICC!

account_circle
vedransolaja(@vedransolaja) 's Twitter Profile Photo

One year ago today my father passed away from or ...precursor for that was infection which usually causes this very rare and very aggressive cancer that spreads very fast. Average age for this condition is 70, my dad was 64.

account_circle
Cholangiocarcinoma Foundation(@curecc) 's Twitter Profile Photo

The 4th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer raised $100,000 for CCA research, the largest amount ever raised for CCF by a single event!

Thank you to the Meyers, race sponsors, donors, runners, cheerleaders, and everyone who supported the event! 💚🎉

The 4th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer raised $100,000 for CCA research, the largest amount ever raised for CCF by a single event!

Thank you to the Meyers, race sponsors, donors, runners, cheerleaders, and everyone who supported the event! 💚🎉
account_circle